Pfizer-BioNTech Omicron-Adapted COVID-19 Vaccine Candidates Elicit Strong Immune Response
Pfizer and BioNTech announced positive findings from a study evaluating 2 Omicron-adapted COVID-19 vaccine candidates. The phase 2/3 trial assessed...
OmicronAdapted
